Katarzyna Jóźwiak (0000-0002-9614-6586)

Personal information

Biography

Dr. Katarzyna Jóźwiak obtained a Master's degree in Applied Mathematics from Delft University, The Netherlands, in 2008, and in Econometrics and Computer Science from the University of Zielona Góra, Poland, in 2009. As a graduate student in Applied Statistics at Utrecht University, The Netherlands, she investigated optimal designs of trials with discrete-time survival endpoints and completed her PhD in 2013. After a brief period as software developer at Utrecht University, Dr. Jóźwiak worked at the Netherlands Cancer Institute in Amsterdam, The Netherlands, till June 2019 where she collaborated as a statistician with clinicians and other researchers of the Institute and the Antoni van Leeuwenhoek hospital. Since 2019, Dr. Jóźwiak is a senior statistician at the Institute of Biostatistics and Registry Research at Brandenburg Medical School Theodor Fontane in Neuruppin, Germany.

Activities

Collapse all

Medizinische Hochschule Brandenburg Theodor Fontane: Neuruppin, DE

2019-07-01 to present | Statistician (Institute of Biostatistics and Registry Research)

Employment

Katarzyna Jóźwiak

https://orcid.org/0000-0002-9614-6586

Personal information

Emails & domains

Verified email domains

Biography

Activities

Employment (3)

Medizinische Hochschule Brandenburg Theodor Fontane: Neuruppin, DE

Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital: Amsterdam, NL

Utrecht University: Utrecht, Utrecht, NL

Education and qualifications (3)

Utrecht University: Utrecht, Utrecht, NL

University of Zielona Góra: Zielona Góra, PL

Delft University of Technology: Delft, Zuid-Holland, NL

Works (50 of 86)

Clinico-pathological characteristics of a distinct tumor phenotype: invasive lobular carcinoma with tubular elements (ILC-TE) in the WSG ADAPTcycle trial

The Role of Genetic Variants in the Prediction of Hearing Loss due to Cisplatin Chemoradiotherapy.

Treatment-related hearing loss in weekly versus triweekly cisplatin chemoradiation for head and neck cancer

Cox Proportional Hazards Regression in Small Studies of Predictive Biomarkers

Prognostic Value of Histopathologic Traits Independent of Stromal Tumor-Infiltrating Lymphocyte Levels in Chemotherapy-Naïve Patients with Triple-Negative Breast Cancer.

Long-Term Outcomes of Young, Node-Negative, Chemotherapy-Naïve, Triple-Negative Breast Cancer Patients according to BRCA1 Status.

Hemiarthroplasty through SuperPATH versus Hemiarthroplasty through Conventional Approaches in Patients with Femoral Neck Fractures: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

The cumulative burden of self-reported, clinically relevant outcomes in long-term childhood cancer survivors and implications for survivorship care: A DCCSS LATER study.

Cumulative Absolute Risk of Subsequent Colorectal Cancer After Abdominopelvic Radiotherapy Among Childhood Cancer Survivors: A PanCareSurFup Study.

External validation and clinical utility assessment of PREDICT breast cancer prognostic model in young, systemic treatment-naïve women with node-negative breast cancer.

Cannulated Screws versus Dynamic Hip Screw versus Hemiarthroplasty versus Total Hip Arthroplasty in Patients with Displaced and Non-Displaced Femoral Neck Fractures: A Systematic Review and Frequentist Network Meta-Analysis of 5703 Patients.

A Scoping Review of Statistical Methods in Studies of Biomarker-Related Treatment Heterogeneity for Breast Cancer.

Nab-Paclitaxel Weekly versus Dose-Dense Solvent-Based Paclitaxel Followed by Dose-Dense Epirubicin plus Cyclophosphamide in High-Risk HR+/HER2- Early Breast Cancer: Results from the Neoadjuvant Part of the WSG-ADAPT-HR+/HER2- Trial.

De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP Trial.

Surgical Site Complications of Isolated Salvage Neck Dissection Post-Radiotherapy and Post-Chemoradiotherapy - A Cohort Analysis (1997-2017).

Development and Validation of Risk Prediction Models for Coronary Heart Disease and Heart Failure After Treatment for Hodgkin Lymphoma.

De-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC): Impact of Molecular Markers and Final Survival Analysis of the WSG-ADAPT-TN Trial

Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy

Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial

Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients

Response to Klar and Adams

Hearing loss among elderly people and access to hearing aids: a cross-sectional study from a rural area in Germany

Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients

Change in cognition before and after non‐central nervous system cancer diagnosis: A population‐based cohort study

Sex Differences in Clinical Course and Intensive Care Unit Admission in a National Cohort of Hospitalized Patients with COVID-19

A Phase I dose‐escalation study of two cycles carboplatin‐olaparib followed by olaparib monotherapy in patients with advanced cancer

Immune cell composition and functional marker dynamics from multiplexed immunohistochemistry to predict response to neoadjuvant chemotherapy in the WSG-ADAPT-TN trial

Variability in grading of ductal carcinoma in situ among an international group of pathologists

Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer

Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls

Brain structure prior to non-central nervous system cancer diagnosis: A population-based cohort study

Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study

Statistical analysis of longitudinal data on tumour growth in mice experiments

Comparison of the Peritoneal Cancer Index and Dutch region count as tools to stage patients with peritoneal metastases of colorectal cancer

Cost-effectiveness analysis of the 70-gene signature compared with clinical assessment in breast cancer based on a randomised controlled trial

Trajectories of Cognitive Function Prior to Cancer Diagnosis: A Population-Based Study

External validation of the American Joint Committee on Cancer 8th edition melanoma staging system: who needs adjuvant treatment?

Lymphovascular invasion and presence of embryonal carcinoma as risk factors for occult metastatic disease in clinical stage I nonseminomatous germ cell tumour: a systematic review and meta-analysis

Platinum exposure and cause‐specific mortality among patients with testicular cancer

Surgical site complications after parotid gland surgery for benign tumors in a centralized setting: A Clavien-Dindo class cohort analysis

Comparing in vivo and ex vivo fiberoptic diffuse reflectance spectroscopy in colorectal cancer

Integrated versus separate reading of F-18 FDG-PET/CT and MRI for abdominal malignancies – effect on staging outcomes and diagnostic confidence

Imaging depth variations in hyperspectral imaging: Development of a method to detect tumor up to the required tumor‐free margin width

Influence of neoadjuvant chemotherapy on diffuse reflectance spectra of tissue in breast surgery specimens

EZH2 Is Overexpressed in <i>BRCA1</i>-like Breast Tumors and Predictive for Sensitivity to High-Dose Platinum-Based Chemotherapy

Factors influencing long‐term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei originating from appendiceal neoplasms

Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck

Salvage surgery for advanced stage head and neck squamous cell carcinoma following radiotherapy or chemoradiation

Inter-observer variation in the histopathology reports of head and neck melanoma; a comparison between the seventh and eighth edition of the AJCC staging system

External validation of the 8th Edition Melanoma Staging System of the American Joint Committee on Cancer (AJCC): Effect of adding EORTC sentinel node (SN) tumor burden criteria on prognostic accuracy in stage III.